Sugi Predict

Sugi Predict / Compounds / SCHEMBL4090068

SCHEMBL4090068

SCHEMBL4090068

CCC(C)NC(=O)c1ccc2c(c1)c(-c1ccc3cc(OCC4CCCN4CC)ccc3c1)nn2[C@@H]1CCCCO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.36
▸ MCHR1 Q99705 1/20 0.35
▸ HTT P42858 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ HDAC4 P56524 2/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ RXRG P48443 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4090069 1.00 TP53 (0.36) TP53MCHR1HTTMAPTALDH1A1
SCHEMBL4079745 0.91 MCHR1 (0.37) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4079746 0.91 MCHR1 (0.37) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4084914 0.91 MCHR1 (0.38) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4085972 0.89 MCHR1 (0.36) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4085969 0.89 MCHR1 (0.36) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4079648 0.89 MCHR1 (0.41) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4089412 0.88 MAPT (0.42) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4089416 0.88 MAPT (0.42) MCHR1HTTMAPTALDH1A1KDM4E
SCHEMBL4170346 0.87 CNR2 (0.40) TP53MCHR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2065383-A1 Indazole compounds and methods of use thereof as protein kinase inhibitors Signal Pharmaceuticals, Inc. (US) 2009-06-03 — — EP disclosed
US-20090099178-A1 INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF BHAGWAT SHRIPAD S 2009-04-16 — — US disclosed
EP-1692128-A1 INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2006-08-23 — — EP disclosed
US-20060004043-A1 Indazole compounds and methods of use thereof BHAGWAT SHRIPAD S 2006-01-05 — — US disclosed
WO-2005051942-A1 INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2005-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099178-A1 INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF WNT3, WNT3A, WNK3 TP53 339/4885MCHR1 2239/4885HTT 1565/4885
US-20060004043-A1 Indazole compounds and methods of use thereof WNT3, WNT3A, WNK3 TP53 338/4885MCHR1 2035/4885HTT 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.